Literature DB >> 22300777

Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.

David J Whellan1, Christopher J Droogan, James Fitzpatrick, Suzanne Adams, Melissa M McCarey, Jocelyn Andrel, Paul Mather, Sharon Rubin, Raphael Bonita, Scott Keith.   

Abstract

BACKGROUND: Despite the high number of admissions for acute decompensated heart failure (ADHF), there are no specific criteria for discharge readiness. A number of patients have implantable devices that might provide data to assist in determining readiness for discharge. METHODS AND
RESULTS: The 3D-HF (Diagnostic Data for Discharge in Heart Failure Patients) study was a prospective observational pilot study enrolling HF patients with Optivol-capable cardiac devices within 48 hours of a hospital admission characterized by worsening HF symptoms. The primary end point was the difference in times from admission to 50% improvement in impedance and to when patient was medically ready for discharge. The nonparametric sign test was used to determine if the difference was significant. A total of 20 subjects were enrolled over a 24-month period. The median ADHF length of stay was 7 days. Of the 20 subjects, 18 achieved the intrathoracic impedance improvement threshold before discharge. The time to reach the threshold for improvement was 2.5 days (interquartile range 2.0-6.0). The difference between days to 50% impedance and days to provider's discharge decision was 3.0 (P = .0072).
CONCLUSIONS: Intrathoracic impedance changes were evident over a short duration in the majority of patients admitted for ADHF and may be a potential criterion for discharge readiness.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22300777     DOI: 10.1016/j.cardfail.2011.10.017

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  2 in total

1.  Accurate monitoring of intravascular fluid volume: A novel application of intrathoracic impedance measures for the guidance of volume reduction therapy.

Authors:  Barbara A Lara; Fujian Qu; E Kevin Heist; Behzad B Pavri; Adrian B Van Bakel; John M Herre; Philip F Binkley
Journal:  Int J Cardiol Heart Vasc       Date:  2015-05-15

2.  The Added Value of In-Hospital Tracking of the Efficacy of Decongestion Therapy and Prognostic Value of a Wearable Thoracic Impedance Sensor in Acutely Decompensated Heart Failure With Volume Overload: Prospective Cohort Study.

Authors:  Christophe J P Smeets; Seulki Lee; Willemijn Groenendaal; Gabriel Squillace; Julie Vranken; Hélène De Cannière; Chris Van Hoof; Lars Grieten; Wilfried Mullens; Petra Nijst; Pieter M Vandervoort
Journal:  JMIR Cardio       Date:  2020-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.